Home >

Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

The inaugural ASCO-SITC Clinical Immuno-Oncology Symposium will have three networking sessions, designed to help physicians determine how immunotherapy best fits into their practice, and to explore career development for newcomers to the field of immunotherapy.
A highly interactive and personal panel discussion and Q&A session will take place in the evening on January 26, before the official opening of the Cancer Survivorship Symposium in San Diego, CA.
Attend the 2017 Cancer Survivorship Symposium's Presidents Panel to hear Drs. Wanda Filer, Nitin Damle, and Julie M. Vose discuss how professional societies are workingto meet the needs of their members with respect to the care of cancer survivors.
This new meeting will focus on the clinical application of immunology to cancer care, including immune checkpoint inhibitor therapy and novel combinations, the use of adoptive T-cell therapy and CAR T-cells, predictive and prognostic biomarkers, and more.
ASCO provides answers to some of the most frequently asked questions about the Society's proposed pathway for Maintenance of Certification, in response to your insightful feedback.
Dr. Smita Bhatia reflects on Dr. Anna T. Meadows' achievements and contributions to the field of survivorship as the 2017 Cancer Survivorship Symposium approaches.
The National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Annual Meeting took place on October 17-18. Here are some highlights on a selection of many of the topics and interactions over that meeting.
Highlights from the 11th annual Best of ASCO Lebanon, attended by more than 300 medical professional from the country and surrounding region.
The ASCO MOC alternate pathway proposal shifts the focus of the recertification process to continuous learning in oncology. As this plan is meant to address your needs, the proposal is presented for your input.
Diane St. Germain and Dr. Sandra Mitchell invite symposium attendees to share their thoughts about gaps in knowledge and priorities for palliative care research in oncology with staff from the National Cancer Institute on Friday, September 9.
Join fellow attendees to discuss mortality and caring for patients with advanced cancer at the third annual Death Cafe at the 2016 Palliative Care in Oncology Symposium.
Dr. Smita Bhatia's Keynote Address will describe an overview of the current knowledge regarding the role of genomic variation in the development of treatment-related late effects.
Ms. Edson, whose experience as a clerk in the cancer and AIDS unit of a research hospital informed her prizewinning play Wit, will serve as one of two Keynote Speakers at the 2016 Palliative Care in Oncology Symposium.
The ASCO Research Community Forum Annual Meeting is in September. As Chair of the Research Community Forum Council, I’m very excited about what’s in store for this year’s meeting and would like to encourage all researchers and research staff to join us for this enriching event.
Sign up today for Expert Office Hours: 25-minute one-on-one meetings with leaders in the field of oncology and palliative care for expert guidance regarding your career development, research, or clinical innovation endeavors.
The ASCO Annual Meeting represents the largest and most important meeting of oncologists in the world, and the benefits of attending are numerous. When I arrived at this year's Annual Meeting, I wondered, how well were women represented?
This year's sessions will feature cutting-edge research and opportunities for oncology, palliative care clinicians, and other health care professionals to network, develop collaborations, learn from one another, and grow professionally.
ASCO composed and successfully brought to the AMA-HOD several resolutions representing some of our most pressing concerns and/or initiatives, including regulations on handling hazardous materials, transparency on clinical pathways, reimbursement models, and Part B drug payments.

Pages


Advertisement